These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 27057681

  • 1. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Afzali A, Park CJ, Zhu K, Hu JK, Sharma P, Sinanan MN, Lee SD.
    Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
    [Abstract] [Full Text] [Related]

  • 2. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 3. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L.
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [Abstract] [Full Text] [Related]

  • 4. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K, Łykowska-Szuber L, Krela-Kaźmierczak I, Eder P, Szymczak A, Stawczyk-Eder K, Linke K.
    Wiad Lek; 2016 Dec; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications.
    Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ.
    Inflamm Bowel Dis; 2002 Sep; 8(5):311-6. PubMed ID: 12479645
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P.
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Sokol H, Seksik P, Carrat F, Nion-Larmurier I, Vienne A, Beaugerie L, Cosnes J.
    Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Risk of postoperative infection in patients with inflammatory bowel disease].
    Ahn HS, Lee SK, Kim HJ, Jang JY, Joo KR, Dong SH, Kim BH, Lee JI, Chang YW, Chang R.
    Korean J Gastroenterol; 2006 Nov; 48(5):306-12. PubMed ID: 17132918
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S, Noble A, Deslandres C.
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recent advances using immunomodulators for inflammatory bowel disease.
    Nielsen OH, Bjerrum JT, Herfarth H, Rogler G.
    J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.
    Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
    [Abstract] [Full Text] [Related]

  • 17. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.